C6K0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Avalo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 16 EUR -0.99% Market Closed

Market Cap: €290.1m

	Avalo Therapeutics Inc F:C6K0	US
	LATAM Airlines Group SA F:LFL	CL
V	Visa Inc SGO:V	US
D	Danaher Corp BMV:DHR	US
M	Microsoft Corp XBER:MSF	US
S	Starbucks Corp XMUN:SRB	US
T	Thales SA OTC:THLLY	FR
F	Fifth Third Bancorp XBER:FFH	US
D	Dominion Energy Inc XBER:DOD	US
U	United Utilities Group PLC F:UUEA	UK
C	Continental AG DUS:CON	DE

Profitability Summary

Avalo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

107%

Gross Margin is Increasing

86% > 100%

Negative Operating Margin

-123.602%

Negative 3Y Average Operating Margin

-20.575%

Declining Operating Margin

-122% > -123.602%

Negative Net Margin

-132.642%

Negative 3Y Average Net Margin

-23.421%

Declining Net Margin

-146% > -132.642%

Negative Free Cash Flow Margin

-87.217%

Negative 3Y Average Free Cash Flow Margin

-16.143%

Declining Free Cash Flow Margin

-115% > -87.217%

Negative ROE

-72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-298%

Declining ROIC

-115% > -428%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.